Leukocyte adhesion deficiency (LAD)

Definition

Leukocyte adhesion deficiency (LAD) is a rare primary immunodeficiency characterized by the inability of leukocytes to adhere to the endothelium and migrate to sites of infection or inflammation. This defect results from mutations in genes that are essential for the expression of integrins on leukocytes, leading to recurrent bacterial infections and impaired wound healing.

5 Must Know Facts For Your Next Test

1. LAD is primarily caused by mutations in the CD18 gene, which encodes a component of the integrin complex necessary for leukocyte adhesion.
2. Patients with LAD often experience recurrent bacterial infections, especially from encapsulated organisms like Staphylococcus and Streptococcus.
3. There are three types of LAD, with Type 1 being the most common, characterized by defects in beta-2 integrins.
4. LAD can lead to severe gum disease and delayed wound healing due to the impaired ability of leukocytes to migrate to infection sites.
5. Treatment options for LAD may include antibiotics to manage infections and stem cell transplantation as a potential curative approach.

Review Questions

• How does leukocyte adhesion deficiency impact the immune response, particularly regarding infection control?
  • Leukocyte adhesion deficiency severely impacts the immune response by preventing leukocytes from adhering to blood vessel walls and migrating to sites of infection. This impairment means that neutrophils and other immune cells cannot effectively reach and combat invading pathogens. As a result, individuals with LAD face an increased risk of recurrent bacterial infections, particularly from organisms that would typically be controlled by a healthy immune system.
• Discuss the genetic basis of leukocyte adhesion deficiency and its implications for diagnosis and treatment.
  • Leukocyte adhesion deficiency is primarily caused by mutations in genes like CD18, which is essential for producing integrins required for leukocyte adhesion. The identification of these genetic mutations is crucial for diagnosing LAD. Genetic testing allows healthcare providers to confirm the diagnosis and differentiate between the types of LAD, informing treatment decisions such as the need for antibiotics to manage infections or consideration of stem cell transplantation as a potential cure.
• Evaluate the long-term consequences of untreated leukocyte adhesion deficiency on patient health and quality of life.
  • Untreated leukocyte adhesion deficiency can lead to significant long-term consequences, including chronic infections that result in damage to various organs and systems. Patients may experience growth retardation, severe gum disease, and poor wound healing, which can further complicate their overall health. These recurrent health issues can greatly affect their quality of life, leading to frequent medical interventions, hospitalizations, and potentially reduced life expectancy if not properly managed.

Related terms

Integrins: Integrins are a family of cell surface receptors that mediate adhesion between cells and the extracellular matrix, playing a critical role in immune response.

Neutrophils:

Neutrophils are a type of white blood cell that are key players in the immune system, particularly in fighting off bacterial infections.

Immunodeficiency: Immunodeficiency refers to a condition in which the immune system's ability to fight infections and diseases is compromised or entirely absent.